Jerrold Sendrow
Director/Board Member at VIRPAX PHARMACEUTICALS, INC.
Net worth: 3 835 $ as of 31/03/2024
Profile
Jerrold Sendrow is an Independent Director at Virpax Pharmaceuticals, Inc. since 2017.
Prior to this, he was a Director at SCILEX Pharmaceuticals, Inc. from 2014 to 2016.
He worked as an Accountant-Audit Departments at Peat Marwick Mitchell & Co. and as Head-Accountant at Touche Ross & Co. He also worked as an Accountant-Audit Departments at Touche Ross & Co. (Australia).
Mr. Sendrow completed his undergraduate degree from Adelphi University and Baruch College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/03/2024 | 900 ( 0.08% ) | 3 835 $ | 31/03/2024 |
Jerrold Sendrow active positions
| Companies | Position | Start |
|---|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Director/Board Member | 01/01/2017 |
Former positions of Jerrold Sendrow
| Companies | Position | End |
|---|---|---|
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Director/Board Member | 01/11/2016 |
| Touche Ross & Co. | Comptroller/Controller/Auditor | - |
| Touche Ross & Co. (Australia) | Comptroller/Controller/Auditor | - |
| Peat Marwick Mitchell & Co. | Comptroller/Controller/Auditor | - |
Training of Jerrold Sendrow
| Adelphi University | Undergraduate Degree |
| Baruch College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
| Peat Marwick Mitchell & Co. | Commercial Services |
| Touche Ross & Co. | Commercial Services |
| Touche Ross & Co. (Australia) | |
| Virpax Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Jerrold Sendrow
